Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-25T00:23:34.996Z Has data issue: false hasContentIssue false
  • English
  • Français

Reasons for Noncompliance With Infection Control Guidelines

Published online by Cambridge University Press:  02 January 2015

Barry M. Farr
Barry M. Farr*
Affiliation:
University of Virginia Health System, Charlottesville, Virginia
*
PO Box 800473, Charlottesville, VA 22908
Get access Rights & Permissions [Opens in a new window]

Abstract

Concern frequently is voiced about individuals not complying with guidelines intended to prevent spread of antibiotic-resistant pathogens from patient to patient, but institutional decisions to ignore Centers for Disease Control and Prevention guidelines recommending detection and isolation of colonized patients also have contributed greatly to the increasing rate of infections due to these pathogens. This is so because colonized patients are the main reservoir for spread, and barrier precautions prevent spread much more effectively than Standard Precautions. Providing effective leadership and changing this culture of noncompliance must begin with the infection control team believing that spread is both important and preventable.

Type
Reviews
Information
Infection Control & Hospital Epidemiology , Volume 21 , Issue 6 , June 2000 , pp. 411 - 416
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Romero-Vivas, J, Rubio, M, Fernandez, C, Picazo, JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus . Clin Infect Dis 1995;21:1417–1423.CrossRefGoogle ScholarPubMed
2. French, GL, Cheng, AF, Ling, JM, Mo, P, Donnan, S. Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 1990;15:117–125.Google Scholar
3. Harbarth, S, Rutschmann, O, Sudre, P, Pittet, D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus . Arch Intern Med 1998;158:182–189.CrossRefGoogle ScholarPubMed
4. Conterno, LO, Wey, SB, Castelo, A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998;19:32–37.Google Scholar
5. Cunney, RJ, McNamara, EB, alAnsari, N, Smyth, EG. Community and hospital acquired Staphylococcus aureus septicaemia: 115 cases from a Dublin teaching hospital. J Infect 1996;33:11–13.CrossRefGoogle ScholarPubMed
6. Suetens, C, Ronveaux, O, Jans, B, Carsauw, H. Mortality impact of antibiotic resistance in Belgian intensive care units (ICUs). Ninth Annual Meeting of the Society for Healthcare Epidemiology of America; April 18-20,1999; San Francisco, CA Abstract 27.Google Scholar
7. Stosor, V, Peterson, L, Postelnick, M, Noskin, G. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998;158:522–527.Google Scholar
8. Edmond, MB, Ober, JF, Weinbaum, DL, Pfaller, MA, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126–1133.Google Scholar
9. Edmond, MB, Ober, JF, Dawson, JD, Weinbaum, DL, Wenzel, RP. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996;23:1234–1239.Google Scholar
10. Feldman, RJ, Paul, S, Cody, R, Noveck, H, Silber, JL, Weinstein, MR. Analysis of treatment for patients with vancomycin-resistant enterococcal bacteremia (VREB). In: Abstracts of the 34th general meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; 1994; Orlando, FL. Abstract J154.Google Scholar
11. Linden, PK, Pasculle, AW, Manez, R, Kramer, DJ, Fung, JJ, Pinna, AD, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium . Clin Infect Dis 1996;22:663–670.Google Scholar
12. Lautenbach, E, Brennan, PJ. Vancomycin resistance and mortality associated with enterococcal bacteremia. Clin Infect Dis 1996;24:530–531.Google Scholar
13. Jernigan, JA, Hadziyannis, SC. Vancomycin-resistant Enterococcus faecium (VRE) bacteremia (B) in severely neutropenic patients. In: Abstracts of the 36th general meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996; New Orleans, LA. Abstract.Google Scholar
14. Vasquez, A, Lutfey, M, Ticci, L, Serrell, F, Kreiswirth, B, Simberkoff, M. Clinical, microbiologic, and epidemiologic evaluation of vancomycin-resistant Enterococcus faecium . In: Abstracts of the 33rd general meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; 1993; Washington, DC. Abstract.Google Scholar
15. Jones, R, Forman, W, O'Donnell, J, Suh, B. High mortality associated with vancomycin-resistant Enterococcus bacteremia. In: Abstracts of the 33rd General Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; 1993; Washington, DC. Abstract.Google Scholar
16. Lam, S, Singer, C, Tucci, V, Morthland, VH, Pfaller, MA, Isenberg, HD. High mortality associated with vancomycin-resistant Enterococcus bacteremia. Am J Infect Control 1995;23:170–180.CrossRefGoogle Scholar
17. Wells, CL, Juni, BA, Cameron, SB, Mason, KR, Dunn, DL, Ferried, P, et al. Stool carriage, isolation, and mortality during outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995;21:45–50.Google Scholar
18. Blot, S, Vandewoude, K, Colardyn, F. Staphylococcus aureus infections. N Engl J Med 1998;339:2025–2027.Google Scholar
19. Abramson, MA, Sexton, DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408–411.Google Scholar
20. Wakefield, DS, Helms, CM, Massanari, RM, Mori, M, Pfaller, MA. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185–192.CrossRefGoogle ScholarPubMed
21. Cheng, AF, French, GL. Methicillin-resistant Staphylococcus aureus bacteraemia in Hong Kong. J Hosp Infect 1988;12:91–101.Google Scholar
22. Muto, CA, Cage, EG, Durbin, LJ, Simonton, BM, Farr, BM. Cost effectiveness of perirectal surveillance cultures for controlling vancomycin resistant Enterococcus. Presented at the Ninth annual meeting of the Society for Healthcare Epidemiology of America. April 18-20, 1999; San Francisco, CA. Abstract 64.Google Scholar
23. Karchmer, TB, Cage, EG, Durbin, LJ, Simonton, BM, Farr, BM. Cost effectiveness of active surveillance cultures for controlling methicillin resistant S aureus (MRSA). Presented at the Ninth annual meeting of the Society for Healthcare Epidemiology of America. April 18-20,1999; San Francisco, CA. Abstract 64.Google Scholar
24. Chaix, C, Durand-Zaleski, I, Alberti, C, Brun-Buisson, C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost benefit analysis in an intensive care unit. JAMA 1999;282:1745–1751.Google Scholar
25. Alexander, Pope. Essay on Criticism. Part ILline 525.Google Scholar
26. Genesis 3:24 (King James version).Google Scholar
27. Matthew, 26:41 (King James version).Google Scholar
28. Centers for Disease Control and Prevention. Surveillance for selected public health indicators affecting older adults—United States. MMWR 1999;48:1–156.Google Scholar
29. Hillman, AL, Ripley, K, Goldfarb, N, Nuamah, I, Weiner, J, Lusk, E. Physician financial incentives and feedback: failure to increase cancer screening in Medicaid managed care. Am J Public Health 1998;88:1699–1701.Google Scholar
30. Hillman, AL, Ripley, K, Goldfarb, N, Weiner, J, Nuamah, I, Lusk, E. The use of physician financial incentives and feedback to improve pediatric preventive care in Medicaid managed care. Pediatrics 1999;104:931–935.Google Scholar
31. Harnick, DJ, Cohen, JL, Schechter, CB, Fuster, V, Smith, DA. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease. Am J Cardiol 1998; 81:1416–1420.Google Scholar
32. Acker, CG, Johnson, JP, Palevsky, PM, Greenberg, A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998;158:917–924.Google Scholar
33. Alanen, KW, Elit, LM, Molinaro, PA, McLachlin, CM. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Cancer 1998;84:5–10.Google Scholar
34. Dexter, PR, Wolinsky, FD, Gramelspacher, GP, Zhou, XH, Eckert, GJ, Waisburd, M, et al. Effectiveness of computer-generated reminders for increasing discussions about advance directives and completion of advance directive forms. A randomized, controlled trial. Ann Intern Med 1998;128:102–110.CrossRefGoogle ScholarPubMed
35. Worrall, G, Freake, D, Kelland, J, Pickle, A, Keenan, T. Care of patients with type II diabetes: a study of family physicians' compliance with clinical practice guidelines. J Fam Pract 1997;44:374–381.Google Scholar
36. Lawler, FH, Viviani, N. Patient and physician perspectives regarding treatment of diabetes: compliance with practice guidelines. J Fam Pract 1997;44:369–373.Google Scholar
37. Doebbeling, BN, Pfaller, MA, Houston, AK, Wenzel, RP. Removal of nosocomial pathogens from the contaminated glove. Implications for glove reuse and handwashing. Ann Intern Med 1988;109:394–398.Google Scholar
38. Olsen, RJ, Lynch, R, Coyle, MB, Cummings, J, Bokete, T, Stamm, WE. Examination gloves as barriers to hand contamination in clinical practice. JAMA 1993;270:350–353.Google Scholar
39. Jernigan, J, Titus, M, Groschel, D, Getchell-White, S, Farr, B. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus . Am J Epidemiol 1996;143:496–504.Google Scholar
40. Fletcher, R, Fletcher, S, Wagner, E. Diagnosis. In: Clinical Epidemiology the Essentials. 1st ed. Baltimore, MD: Williams & Wilkins; 1982:93.Google Scholar
41. Haley, RW, Cushion, NB, Tenover, FC, Bannerman, TL, Dryer, D, Ross, J, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171:614–624.Google Scholar
42. Montecalvo, MA, Jarvis, WR, Uman, J, Shay, DK, Petrullo, C, Rodney, K, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med 1999;131:269–272.Google Scholar
43. Soderland, N, Zwi, K, Kinghorn, A, Gray, G. Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa. BMJ 1999;318:1650–1656.Google Scholar
44. Snyder, DC, Paz, EA, Mohle-Boetani, JC, Fallstad, R, Black, RL, Chin, DP. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness. Am J Respir Crit Care Med 1999;160:178–185.Google Scholar
45. Grover, SA, Coupal, L, Paquet, S, Zowall, H. Cost-effectiveness of 3-hydroxy-3-methyglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events. Arch Intern Med 1999;159:593–600.Google Scholar
46. Mohle-Boetani, JC, Lieu, TA, Ray, GT, Escobar, G. Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics 1999;103:703–710.Google Scholar
47. Smith, WJ, Jackson, LA, Watts, DH, Koespell, TD. Prevention of chicken-pox in reproductive-age women: cost-effectiveness of routine prenatal screening with postpartum vaccination of susceptibles. Obstet Gynecol 1998;92(4 Pt 1):535–545.Google Scholar
48. Pinkerton, SD, Holtgrave, DR, DiFranceisco, WJ, Stevenson, LY, Kelly, JA. Cost-effectiveness of a community-level HIV risk reduction intervention. Am J Public Health 1998;88:1239–1242.Google Scholar
49. Sisk, JE, Moskowitz, AJ, Whang, W, Lin, JD, Fedson, DS, McBean, AM, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278:1333–1339.Google Scholar
50. Garner, JS, Favero, MS, Hospital Infections Program, Centers for Disease Control. Handwashing and hospital environmental control. In: CDC Guideline for Handwashing and Hospital Environmental Control, 1985. Atlanta, GA: CDC; 1985:7–9.Google Scholar
51. Larson, EL. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995;23:251–269.Google Scholar
52. Larson, E, Kretzer, EK. Compliance with handwashing and barrier precautions. J Hosp Infect 1995;30:88–106.Google Scholar
53. Larson, E. Compliance with isolation technique. Am J Infect Control 1983;11:221–225.Google Scholar
54. Slaughter, S, Hayden, MK, Nathan, C, Hu, TC, Rice, T, Van Voorhis, J, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448–456.Google Scholar
55. Larson, E, Killien, M. Factors influencing handwashing behavior of patient care personnel. Am J Infect Control 1982;10:93–99.Google Scholar
56. Zimakoff, J, Kjelsberg, AB, Larsen, SO, Holstein, B. A multicenter questionnaire investigation of attitudes toward hand hygiene, assessed by the staff in fifteen hospitals in Denmark and Norway. Am J Infect Control 1992;20:58–64.Google Scholar
57. Pettinger, A, Nettleman, MD. Epidemiology of isolation precautions. Infect Control Hosp Epidemiol 1991;12:303–307.Google Scholar
58. Pittet, D, Mourouga, P, Perneger, TV. Compliance with handwashing in a teaching hospital. Ann Intern Med 1999;130:126–130.Google Scholar
59. Fridkin, SA, Pear, SM, Williamson, TH, Galgiani, JN, Jarvis, WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1996;17:150–158.Google Scholar
60. Farr, BM. Understaffing: a risk factor for infection in the era of downsizing? Infect Control Hosp Epidemiol 1996;17:150–158.Google Scholar
61. Newman, JL, Seitz, JC. Intermittent use of an antimicrobial hand gel for reducing soap-induced irritation of health care personnel. Am J Infect Control 1990;18:194–200.CrossRefGoogle ScholarPubMed
62. Ojajarvi, J. Handwashing in Finland. J Hosp Infect 1991;18:35–40.Google Scholar
63. Boyce, JM. Kelliher, S, Vallande, N. Skin irritation and dryness associated with two hand-hygiene regimens: soap and water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol. In press.Google Scholar
64. Pittet, D. Improving hand-hygiene adherence using a multidisciplinary approach. Presented at the 4th Decennial International Conference on Nosocomial and Healthcare Associated Infections in conjunction with the 10th Annual Meeting of the Society for Healthcare Epidemiology of America; March 4-9, 2000; Atlanta, GA.Google Scholar
65. Larson, EL. Compliance obstacles and measures to increase compliance in traditional non-traditional areas. Presented at the Ninth Annual Meeting of the Society for Healthcare Epidemiology of America; April 18-20,1999; San Francisco, CA. Symposium IV.Google Scholar
66. Hayden, F. Preventing influenza in acute care settings. Presented at the CDC 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections in conjunction with the 10th Annual Meeting of the Society for Healthcare Epidemiology of America; March 4-9,2000; Atlanta, GA.Google Scholar
67. Thompson, RL, Cabezudo, I, Wenzel, RP. Epidemiology of nonsocial infections caused by methicillin-resistant Staphylococcus aureus . Ann Intern Med 1982;97:309–317.Google Scholar
68. Monnet, D. Plenary Session. Global Conference on Antibiotic Resistance; March 1999; Toronto, Ontario, Canada.Google Scholar
69. Bager, F, ed. DANMAP 98—Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria From Food Animals, Food and Humans in Denmark. Copenhagen, Denmark: Danish Zoonosis Centre; 1999. Available from http://www.svs.dk/dk/z/Danmap%201998.pd (Note: to view, rename suffix “.pdf”.)Google Scholar